2505 Meridian Parkway Suite 340
Durham, NC 27713

Chimerix News

Chimerix's new smallpox drug looks promising in animal tests

Tuesday, Feb 9, 2016 @ 7:49pm by BioPrepWatch Reports

Chimerix recently received positive results concerning smallpox drug brincidofovir, which has been able to act against smallpox in animal subjects.
Read More »

BARDA extends Chimerix contract

Tuesday, Sep 15, 2015 @ 10:30am by BioPrepWatch Reports

$13 million extension will allow company to continue exploring brincidofovir as possible smallpox treatment.
Read More »

Chimerix meets enrollment goals for brincidofovir clinical trials

Wednesday, Sep 9, 2015 @ 9:26am by BioPrepWatch Reports

Antiviral candidate being tested for prevention of cytomegalovirus and treatment of adenovirus infection.
Read More »

Chimerix reports positive results in smallpox treatment trials

Thursday, Jul 23, 2015 @ 6:34pm by BioPrepWatch Reports

Chimerix, Inc. announced Thursday that their countermeasure against smallpox, brincidofovir, has seen positive results in animal models.
Read More »

Chimerix to present at JMP conference

Thursday, Jun 18, 2015 @ 5:26pm by BioPrepWatch Reports

Chimerix Inc. has announced it will be presenting at the JMP Life Sciences Conference on June 24.
Read More »

Chimerix to cease clinical trials on Ebola vaccine

Monday, Feb 2, 2015 @ 5:35pm by BioPrepWatch Reports

Chimerix, Inc. announced on Friday that research and development into their potential vaccine against the Ebola virus.
Read More »

Chimerix summarizes highlights of 2014

Tuesday, Dec 23, 2014 @ 3:49pm by BioPrepWatch Reports

Chimerix, Inc. released their end of the year report on what has happened in the development of antiviral medicine, specifically the testing process of their brincidofovir (BCV) Ebola treatment candidate, on Tuesday.
Read More »

Chimerix names two new executives

Wednesday, Nov 5, 2014 @ 11:57am by BioPrepWatch Reports

Chimerix Inc. named Peter Payne senior vice president of business development and corporate strategy, and Roberto Guzman vice president of corporate compliance on Monday.
Read More »